VORBEUGUNG UND BEHANDLUNG VON OXIDATIVER-STRESS-ERKRANKUNGEN MIT VERBINDUNGEN DIE DEN INTRAZELLULÄREN SPIEGEL VON GLUTATHION ODER PHASE-II-ENTGIFTUNGSENZYMEN ERHÖHEN

摘要

The present invention generally relates to the field of treating oxidative stress disorders by administering a pharmaceutically effective amount of a compound that elevates the intracellular levels of glutathione or intracelluar levels of at least one Phase II detoxification enzyme in animal tissue. The present invention also relates to the field of protecting a subject from photooxidation or oxidative stress disorders by administering a pharmaceutically effective amount of a compound that elevates the intracellular levels of glutathione or intracellular levels of at least one Phase II detoxification enzyme in the subject. The present invention also relates to a pharmaceutical composition useful for the treatment of oxidative stress disorders.